Siemens Japan acquires majority stake of Mochida Siemens Medical Systems
3 October 2007
Mochida Pharmaceutical Co Ltd and Siemens KK Japan have agreed to
change the ownership interest both companies hold in their joint venture
Mochida Siemens Medical Systems Co Ltd. Mochida Pharmaceutical has
transferred 16% of its outstanding shares to Siemens KK, making Siemens KK a
51% equity stakeholder.
The share transfer means that Mochida Siemens Medical Systems Co., Ltd
will become a fully consolidated subsidiary of Siemens and an
equity-consolidated affiliate of Mochida Pharmaceutical Co Ltd.
The joint venture’s current President, and Representative Director,
Shuichi Ishii, will retain his position and take on additional
responsibilities as the company’s Chief Operating Officer (COO). Holger
Klotz, currently the Managing Director and CEO of Mobisphere Ltd., a Siemens
and NEC Joint Venture, will join the management team as CEO, Chairman and
Since its formation in 2004, the joint venture Mochida Siemens Medical
Systems has steadily expanded its business in the diagnostic ultrasound
market in Japan, especially in the obstetrics and gynaecology market where
it holds a significant market share.
With the new International management and a comprehensive product and
applications portfolio, Siemens-Mochida plans to expand its position in the
cardiovascular and internal medicine markets, addressing the health issues
in Japan across the entire spectrum of ultrasound solutions.
Save this page on del.icio.us